294 related articles for article (PubMed ID: 14729970)
81. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
82. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
[TBL] [Abstract][Full Text] [Related]
83. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
[TBL] [Abstract][Full Text] [Related]
84. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
85. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
86. The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells.
Rutherford MN; Bayly GR; Matthews BP; Okuda T; Dinjens WM; Kondoh H; LeBrun DP
Leukemia; 2001 Mar; 15(3):362-70. PubMed ID: 11237058
[TBL] [Abstract][Full Text] [Related]
87. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
88. Levels of E2A protein expression in B cell precursors are stage-dependent and inhibited by stem cell factor (c-kit ligand).
Riley RL; Knowles J; King AM
Exp Hematol; 2002 Dec; 30(12):1412-8. PubMed ID: 12482503
[TBL] [Abstract][Full Text] [Related]
89. Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia.
Yuan N; Song L; Lin W; Cao Y; Xu F; Liu S; Zhang A; Wang Z; Li X; Fang Y; Zhang H; Zhao W; Hu S; Wang J; Zhang S
Blood Cancer J; 2015 Jan; 5(1):e274. PubMed ID: 25615280
[TBL] [Abstract][Full Text] [Related]
90. B-cell development fails in the absence of the Pbx1 proto-oncogene.
Sanyal M; Tung JW; Karsunky H; Zeng H; Selleri L; Weissman IL; Herzenberg LA; Cleary ML
Blood; 2007 May; 109(10):4191-9. PubMed ID: 17244677
[TBL] [Abstract][Full Text] [Related]
91. Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations.
Kawamata S; Du C; Li K; Lavau C
Oncogene; 2002 May; 21(24):3855-63. PubMed ID: 12032823
[TBL] [Abstract][Full Text] [Related]
92. E2A proteins enforce a proliferation checkpoint in developing thymocytes.
Engel I; Murre C
EMBO J; 2004 Jan; 23(1):202-11. PubMed ID: 14685278
[TBL] [Abstract][Full Text] [Related]
93. Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.
Gow CH; Guo C; Wang D; Hu Q; Zhang J
Nucleic Acids Res; 2014 Jan; 42(1):137-52. PubMed ID: 24064250
[TBL] [Abstract][Full Text] [Related]
94. Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.
Bjerke GA; Hyman-Walsh C; Wotton D
Mol Cell Biol; 2011 Sep; 31(18):3723-33. PubMed ID: 21746878
[TBL] [Abstract][Full Text] [Related]
95. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1.
Knoepfler PS; Kamps MP
Mol Cell Biol; 1995 Oct; 15(10):5811-9. PubMed ID: 7565734
[TBL] [Abstract][Full Text] [Related]
96. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
Fu X; Kamps MP
Mol Cell Biol; 1997 Mar; 17(3):1503-12. PubMed ID: 9032278
[TBL] [Abstract][Full Text] [Related]
97. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
Hunger SP; Galili N; Carroll AJ; Crist WM; Link MP; Cleary ML
Blood; 1991 Feb; 77(4):687-93. PubMed ID: 1671560
[TBL] [Abstract][Full Text] [Related]
98. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2.
van Dijk MA; Peltenburg LT; Murre C
Mech Dev; 1995 Jul; 52(1):99-108. PubMed ID: 7577680
[TBL] [Abstract][Full Text] [Related]
99. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
100. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells.
Thorsteinsdottir U; Krosl J; Kroon E; Haman A; Hoang T; Sauvageau G
Mol Cell Biol; 1999 Sep; 19(9):6355-66. PubMed ID: 10454582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
